These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36628563)

  • 1. Is high accuracy of Vesical Imaging-Reporting and Data System (VI-RADS) sufficient for its implementation in the urological practice?
    Rysankova K; Hanzlikova P; Zidlik V; Vrtkova A; Slisarenko M; Skarda J; Grepl M; Krhut J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2023 Mar; 167(1):85-90. PubMed ID: 36628563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
    Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
    Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center.
    Barchetti G; Simone G; Ceravolo I; Salvo V; Campa R; Del Giudice F; De Berardinis E; Buccilli D; Catalano C; Gallucci M; Catto JWF; Panebianco V
    Eur Radiol; 2019 Oct; 29(10):5498-5506. PubMed ID: 30887202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease?
    Del Giudice F; Leonardo C; Simone G; Pecoraro M; De Berardinis E; Cipollari S; Flammia S; Bicchetti M; Busetto GM; Chung BI; Gallucci M; Catalano C; Panebianco V
    BJU Int; 2020 Nov; 126(5):610-619. PubMed ID: 32783347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and reliability of VI-RADS in determining candidates for repeated transurethral resection in patients with high-risk non-muscle invasive bladder cancer.
    Erkoc M; Otunctemur A; Bozkurt M; Can O; Atalay HA; Besiroglu H; Danis E; Degirmentepe RB
    Int J Clin Pract; 2021 Sep; 75(9):e14584. PubMed ID: 34185372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of vesical imaging-reporting and data system (VI-RADS) in non-muscle invasive bladder cancer (NMIBC) patients candidate for en-bloc transurethral resection: A prospective study.
    El-Karamany TM; Al-Adl AM; Hosny MM; A Eldeep H; El-Hamshary SA
    Urol Oncol; 2022 Oct; 40(10):454.e1-454.e7. PubMed ID: 35466036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of multiparametric magnetic resonance imaging in bladder cancer (Vesical Imaging-Reporting and Data System): A systematic review.
    Carando R; Afferi L; Marra G; Krajewski W; Pagliarulo V; Abufaraj M; Xylinas E; Cathelineau X; Sanchez-Salas R; Moschini M
    Arab J Urol; 2020 Mar; 18(2):67-71. PubMed ID: 33029409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of VI-RADS in predicting muscle-invasive bladder cancer after transurethral resection: a single center retrospective analysis.
    Chai JL; Roller LA; Liu X; Lan Z; Mossanen M; Silverman SG; Shinagare AB
    Abdom Radiol (NY); 2024 May; 49(5):1593-1602. PubMed ID: 38502214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VI-RADS: Multiinstitutional Multireader Diagnostic Accuracy and Interobserver Agreement Study.
    Ueno Y; Tamada T; Takeuchi M; Sofue K; Takahashi S; Kamishima Y; Urase Y; Kido A; Hinata N; Harada K; Fujisawa M; Miyaji Y; Murakami T
    AJR Am J Roentgenol; 2021 May; 216(5):1257-1266. PubMed ID: 32755215
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel utility of Vesical Imaging-Reporting and Data System in multimodal treatment for muscle-invasive bladder cancer.
    Kimura K; Yoshida S; Tsuchiya J; Kitazume Y; Waseda Y; Tanaka H; Yokoyama M; Toda K; Yoshimura R; Masaya I; Koga F; Tateishi U; Fujii Y
    Eur Radiol; 2023 Sep; 33(9):6245-6255. PubMed ID: 37045982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposal for a New Vesical Imaging-Reporting and Data System (VI-RADS)-Based Algorithm for the Management of Bladder Cancer: A Paradigm Shift From the Current Transurethral Resection of Bladder Tumor (TURBT)-Dependent Practice.
    Taguchi S; Watanabe M; Tambo M; Machida H; Yokoyama K; Fukuhara H
    Clin Genitourin Cancer; 2022 Aug; 20(4):e291-e295. PubMed ID: 35346591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of multiparametric MRI based Vesical Imaging-Reporting and Data System (VI-RADS) scoring in discriminating between non-muscle invasive and muscle invasive bladder cancer.
    Islam NU; Jehangir M; Parry AH; Nazir SS; Bilal S
    Pol J Radiol; 2023; 88():e356-e364. PubMed ID: 37701172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The accuracy of Vesical Imaging-Reporting and Data System (VI-RADS): an updated comprehensive multi-institutional, multi-readers systematic review and meta-analysis from diagnostic evidence into future clinical recommendations.
    Del Giudice F; Flammia RS; Pecoraro M; Moschini M; D'Andrea D; Messina E; Pisciotti LM; De Berardinis E; Sciarra A; Panebianco V
    World J Urol; 2022 Jul; 40(7):1617-1628. PubMed ID: 35294583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparametric MRI in differentiation between muscle invasive and non-muscle invasive urinary bladder cancer with vesical imaging reporting and data system (VI-RADS) application.
    Makboul M; Farghaly S; Abdelkawi IF
    Br J Radiol; 2019 Dec; 92(1104):20190401. PubMed ID: 31573328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vesical Imaging-Reporting and Data System for Multiparametric MRI to Predict the Presence of Muscle Invasion for Bladder Cancer.
    Hong SB; Lee NK; Kim S; Son IW; Ha HK; Ku JY; Kim KH; Park WY
    J Magn Reson Imaging; 2020 Oct; 52(4):1249-1256. PubMed ID: 32220105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biparametric versus Multiparametric Magnetic Resonance Imaging for Assessing Muscle Invasion in Bladder Urothelial Carcinoma with Variant Histology Using the Vesical Imaging-Reporting and Data System.
    Arita Y; Kwee TC; Woo S; Shigeta K; Ishii R; Okawara N; Edo H; Waseda Y; Vargas HA
    Eur Urol Focus; 2024 Jan; 10(1):131-138. PubMed ID: 37633790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could Bladder Multiparametric MRI Be Introduced in Routine Clinical Practice? Role of the New VI-RADS Score: Results From a Prospective Study.
    Marchioni M; Primiceri G; Delli Pizzi A; Basilico R; Berardinelli F; Mincuzzi E; Castellucci R; Sessa B; Di Nicola M; Schips L
    Clin Genitourin Cancer; 2020 Oct; 18(5):409-415.e1. PubMed ID: 32273236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer detection from multiparametric magnetic resonance imaging.
    Jai-Ua C; Limpaiboon C; Siriboonrid S; Binsri N; Kanjanatarayon S; Wiriyabanditkul W; Jiraanankul V
    Investig Clin Urol; 2023 Nov; 64(6):546-553. PubMed ID: 37932565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel pathway to detect muscle-invasive bladder cancer based on integrated clinical features and VI-RADS score on MRI: results of a prospective multicenter study.
    Bicchetti M; Simone G; Giannarini G; Girometti R; Briganti A; Brunocilla E; Cardone G; De Cobelli F; Gaudiano C; Del Giudice F; Flammia S; Leonardo C; Pecoraro M; Schiavina R; Catalano C; Panebianco V
    Radiol Med; 2022 Aug; 127(8):881-890. PubMed ID: 35763251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of vesical imaging-reporting and data system (VI-RADS) in suspected muscle invasive bladder cancer: A systematic review and diagnostic meta-analysis.
    Jazayeri SB; Dehghanbanadaki H; Hosseini M; Taghipour P; Alam MU; Balaji KC; Bandyk M
    Urol Oncol; 2022 Feb; 40(2):45-55. PubMed ID: 34895996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.